The US Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular ...

Biotech company Neurotech Pharmaceuticals this month received regulatory approval for its treatment of a a neurodegenerative ...

Altris AI, which offers OCT analysis for retinal diseases, is now expanding to glaucoma detection.With its optic disc ...

This milestone marks a significant step forward in Rakovina’s mission to accelerate drug discovery using advanced AI-driven platforms. In September 2024, Rakovina announced its partnership with ...

Rakovina Therapeutics Inc. (TSX-V: RKV)(FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial ...

The Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular telangiectasia type 2 (MacTel).

First Xolair biosimilar approved; wearable furosemide delivery system gains expanded indication; implant approved for macular telangiectasia; novel treatment shows promise in hypertension; and testing ...

Symptom severity, meibum quality, and telangiectasia are factors affecting prognostic outcomes for intense pulsed light therapy.

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

2021 will be the year when big market access changes – including the far wider use of health economic evaluation – are implemented in Spain. In the latest of a suite of features looking at the ...

After hours: March 14 at 7:14:01 PM EDT Loading Chart for SHPH ...

At close: March 13 at 4:00:00 PM EDT Loading Chart for GRCE ...